Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Reina Tsuda, Koichiro Shinoda, Ryuichi Ushijima, Makiko Nakamura, Nagaaki Katoh, Johji Imura & Kazuyuki Tobe. (2021) A case of wild-type transthyretin cardiac amyloidosis with rheumatoid arthritis. Modern Rheumatology Case Reports 5:2, pages 206-213.
Read now
Read now
Tadashi Nakamura, Naoki Shiraishi, Yasuhiro Morikami, Hiromi Fujii & Takeshi Yoshinaga. (2020) Amyloid A amyloidosis in a patient with Caplan’s syndrome, with special reference to genetic predisposition. Modern Rheumatology Case Reports 4:2, pages 212-217.
Read now
Read now
Omer Nuri Pamuk, Salim Donmez, Gulsum Emel Pamuk, Fulya Oz Puyan & Edward C. Keystone. (2013) Turkish experience in rheumatoid arthritis patients with clinical apparent amyloid deposition. Amyloid 20:4, pages 245-250.
Read now
Read now
Y Wada, D Kobayashi, S Murakami, M Oda, H Hanawa, T Kuroda, M Nakano & I Narita. (2011) Cardiac AA amyloidosis in a patient with rheumatoid arthritis and systemic sclerosis: the therapeutic potential of biological reagents. Scandinavian Journal of Rheumatology 40:5, pages 402-404.
Read now
Read now
Barbara Kluve-Beckerman, Joyce Hardwick, Lijing Du, Merrill D. Benson, Brett P. Monia, Andrew Watt, Rosanne M. Crooke & Adam Mullick. (2011) Antisense oligonucleotide suppression of serum amyloid A reduces amyloid deposition in mice with AA amyloidosis. Amyloid 18:3, pages 136-146.
Read now
Read now
Charles J Malemud. (2009) Recent advances in neutralizing the IL-6 pathway in arthritis. Open Access Rheumatology: Research and Reviews 1, pages 133-150.
Read now
Read now
Articles from other publishers (17)
Nicole K. Andeen, Lanny DiFranza, Vanderlene L. Kung, Kammi Henriksen, Renu Gupta, Kumar Dinesh, Shreeram Akilesh, Satoru Kudose, Kelly D. Smith & Megan L. Troxell. (2023) AA amyloidosis With Ig-Dominant Staining and Diagnostically Unusual Features. Kidney International Reports.
Crossref
Crossref
Martyna Maszota-Zieleniak, Annemarie Danielsson & Sergey A. Samsonov. (2021) The potential role of glycosaminoglycans in serum amyloid A fibril formation by in silico approaches. Matrix Biology Plus 12, pages 100080.
Crossref
Crossref
Levent Kilic, Abdulsamet Erden, Yusuf Sener, Berkan Armagan, Alper Sari, Umut Kalyoncu, Omer Karadag, Ali Akdogan, Ismail Dogan, Sule Apras Bilgen, Sedat Kiraz & Ihsan Ertenli. (2018) Rituximab Therapy in Renal Amyloidosis Secondary to Rheumatoid Arthritis. Biomolecules 8:4, pages 136.
Crossref
Crossref
János G. Filep, Meriem Sekheri & Driss El Kebir. (2018) Targeting formyl peptide receptors to facilitate the resolution of inflammation. European Journal of Pharmacology 833, pages 339-348.
Crossref
Crossref
Shunji Ishihara, Yasumasa Tada, Kousaku Kawashima, Masatoshi Kataoka, Hiroki Sonoyama, Noritsugu Yamashita, Akihiko Oka, Ryusaku Kusunoki, Nobuhiko Fukuba, Yoshiyuki Mishima, Naoki Oshima, Ichiro Moriyama, Takafumi Yuki & Yoshikazu Kinoshita. (2018) Serum amyloid A level correlated with endoscopic findings in patients with Crohn’s disease—Possible biomarker for evaluating mucosal healing. Digestive and Liver Disease 50:6, pages 553-558.
Crossref
Crossref
. 2016. Diagnostic Imaging: Musculoskeletal Non-Traumatic Disease. Diagnostic Imaging: Musculoskeletal Non-Traumatic Disease
126
131
.
John R. Dye, Mala S. Kaul & E. William St. Clair. 2015. PanVascular Medicine. PanVascular Medicine
1885
1916
.
Lia Millucci, Lorenzo Ghezzi, Giulia Bernardini, Daniela Braconi, Pietro Lupetti, Federico Perfetto, Maurizio Orlandini & Annalisa Santucci. (2014) Diagnosis of secondary amyloidosis in alkaptonuria. Diagnostic Pathology 9:1.
Crossref
Crossref
Lia Millucci, Adriano Spreafico, Laura Tinti, Daniela Braconi, Lorenzo Ghezzi, Eugenio Paccagnini, Giulia Bernardini, Loredana Amato, Marcella Laschi, Enrico Selvi, Mauro Galeazzi, Alessandro Mannoni, Maurizio Benucci, Pietro Lupetti, Federico Chellini, Maurizio Orlandini & Annalisa Santucci. (2012) Alkaptonuria is a novel human secondary amyloidogenic disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1822:11, pages 1682-1691.
Crossref
Crossref
Tim Jansen, Piet van Riel & Paul-Peter TakTim Jansen. 2012. Reumatologie in beeld. Reumatologie in beeld
39
41
.
E Hatanaka, A Dermargos, H A Armelin, R Curi & A Campa. (2011) Serum amyloid A induces reactive oxygen species (ROS) production and proliferation of fibroblast. Clinical and Experimental Immunology 163:3, pages 362-367.
Crossref
Crossref
R. Michael Benitez, Gautam Ramani & Patricia A. Uber. 2011. Rheumatology. Rheumatology
305
313.e2
.
Raine Tatara, Tadashi Nagai, Hiroyuki Kobayashi, Kaoru Hatano, Takahiro Suzuki, Kazuo Muroi & Keiya Ozawa. (2010) AA amyloidosis associated with macroglobulinemia. International Journal of Hematology 92:4, pages 675-677.
Crossref
Crossref
Laima Leonavičienė, Danutė Povilėnaitė, Rūta Bradūnaitė, Dalia Vaitkienė & Algirdas Venalis. (2010) Treatment of experimental amyloidosis with antirheumatic drugsEksperimentinės amiloidozės gydymas priešreumatiniais vaistais. Acta medica Lituanica 17:1, pages 17-29.
Crossref
Crossref
Daisuke Takeuchi, Naohiko Koide, Masato Kitazawa, Kazuhiro Fukushima, Masayuki Matsuda, Mana Fukushima & Shinichi Miyagawa. (2009) Perforation of rectal diverticulum with amyloidosis secondary to rheumatoid arthritis: case report and review of the literature. Clinical Journal of Gastroenterology 3:1, pages 30-35.
Crossref
Crossref
Laura Obici, Sara Raimondi, Francesca Lavatelli, Vittorio Bellotti & Giampaolo Merlini. (2009) Susceptibility to AA amyloidosis in rheumatic diseases: A critical overview. Arthritis & Rheumatism 61:10, pages 1435-1440.
Crossref
Crossref
M.V. Irigoyen Oyarzábal, M. López Lasanta, I. Ureña Garnica & A. Fernández-Nebro. (2009) Amiloidosis. Medicine - Programa de Formación Médica Continuada Acreditado 10:33, pages 2185-2191.
Crossref
Crossref